This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Avidity Biosciences, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Georgios Karamanlidis: Innovator in Antibody-Oligonucleotide Conjugates
Introduction
Georgios Karamanlidis is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic methods.
Latest Patents
Karamanlidis holds a patent for "Compositions and Methods of Using PRKAG2-Targeting Antibody-Oligonucleotide Conjugates." This invention represents a breakthrough in targeted therapies, showcasing his expertise in combining antibodies with oligonucleotides for enhanced treatment efficacy.
Career Highlights
Currently, Georgios is associated with Avidity Biosciences, Inc., where he continues to push the boundaries of scientific research and innovation. His work focuses on developing novel therapeutic strategies that leverage the power of antibody-oligonucleotide conjugates.
Collaborations
Throughout his career, Karamanlidis has collaborated with talented professionals, including Maryam Jordan and Subbarao Nallagatla. These partnerships have fostered a dynamic research environment, leading to advancements in their shared field.
Conclusion
Georgios Karamanlidis is a key figure in the biotechnology sector, with a focus on innovative therapeutic solutions. His contributions, particularly in antibody-oligonucleotide conjugates, highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile